ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,027Medicare Part D Prescriptions Filled, Including Refills

Rank: 408 out of 3001

$655K Total Retail Price of All Prescriptions

Rank: 341 out of 3001

407 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 407 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 407 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,240 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 496 363 1 1
LISINOPRIL 439 311 2 2
LEVOTHYROXINE SODIUM 363 217 3 3
PRAVASTATIN SODIUM 269 179 4 13
TRAMADOL HCL 214 121 5 17
OMEPRAZOLE 211 125 6 4
PROAIR HFA 210 126 7 30
GABAPENTIN 204 86 8 14
AMLODIPINE BESYLATE 193 150 9 5
FUROSEMIDE 190 138 10 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 187 124 11 22
ATORVASTATIN CALCIUM 159 99 12 11
METFORMIN HCL 155 91 13 9
CLOPIDOGREL 153 104 14 28
GLIMEPIRIDE 148 111 15 31
METOPROLOL TARTRATE 144 99 16 8
MELOXICAM 134 76 17 34
SPIRIVA 132 69 18 57
ATENOLOL 119 107 19 18
HYDROCHLOROTHIAZIDE 118 89 20 10
LOSARTAN POTASSIUM 108 90 21 21
ALLOPURINOL 95 75 22 35
PANTOPRAZOLE SODIUM 94 68 23 43
ADVAIR DISKUS 94 75 23 58
NEXIUM 88 50 25 23
TRAZODONE HCL 87 45 26 37
METFORMIN HCL ER 83 65 27 51
POTASSIUM CHLORIDE 81 41 28 15
CITALOPRAM HBR 79 34 29 16
CARVEDILOL 79 49 29 25
PLAVIX 76 51 31 46
CYMBALTA 73 22 32 53
ZOLPIDEM TARTRATE 73 48 32 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 49 34 77
LANTUS SOLOSTAR 71 55 35 80
ROPINIROLE HCL 66 43 36 88
METOPROLOL SUCCINATE 65 65 37 19
FAMOTIDINE 65 18 37 68
AZITHROMYCIN 65 31 37 36
SYMBICORT 63 30 40 155
PROPRANOLOL HCL 62 0 41 136
AMOXICILLIN 62 43 41 107
ZETIA 62 23 41 69
WARFARIN SODIUM 60 51 44 12
LOVAZA 60 27 44 168
FENOFIBRATE 57 39 46 59
CRESTOR 55 23 47 33
TAMSULOSIN HCL 55 19 47 29
CYCLOBENZAPRINE HCL 54 23 R 49 73
LANSOPRAZOLE 51 35 50 140
OXYBUTYNIN CHLORIDE 50 24 51 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.